Portage, MI, United States of America

Chiu-Hong Lin

This inventor holds 30 USPTO granted patents, plus 1 CIPO patent, primarily in Pharmaceutical Chemistry. Top assignees: The Upjohn Co., Pharmacia & Upjohn Company, Other. Active years: 1977-2005.


% Patents Active = 93.3

 

Average Co-Inventor Count = 1.7

ph-index = 7

Forward Citations = 139(Granted Patents)


Location History:

  • Kalamazoo County, MI (US) (1984)
  • Kalamazoo, MI (US) (1996)
  • Portage, MI (US) (1977 - 2005)

Company Filing History:


Years Active: 1977-2005

Loading Chart...
Loading Chart...
Areas of Expertise:
CNS Treatments
Dopamine D3 Ligands
Heterocyclic Compounds
Aminoindans
Carbocyclic Derivatives
Thromboxane A.sub.2
Imidazolyl Compounds
PGE.sub.2 Analogs
Anti-Diabetic Compounds
Bicyclic Amines
Naphthalenediol Derivatives
2-Aminotetralin Derivatives
30 patents (USPTO):Explore Patents

Title: Contributions of Chiu-Hong Lin to Pharmaceutical Innovations

Introduction: Chiu-Hong Lin, based in Portage, MI, is a prominent inventor in the pharmaceutical field. With a remarkable portfolio consisting of 30 patents, Lin has made significant contributions to the development of innovative drug processes.

Latest Patents: Among his latest patents is a notable process for preparing 2-aminoindan derivatives. This invention pertains specifically to (2S)-enantiomers of 2-aminoindan derivatives of formula I, offering a novel method for their preparation.

Career Highlights: Lin's career has been marked by his influential roles at major companies such as The Upjohn Company and Pharmacia & Upjohn Company. His experience at these organizations has provided him with the foundation to innovate and advance pharmaceutical science.

Collaborations: Throughout his career, Lin has collaborated with esteemed colleagues, including Susanne R Haadsma-Svensson and Arthur Glenn Romero. These collaborations have played a key role in refining his research and expanding the reach of his innovations.

Conclusion: Chiu-Hong Lin exemplifies the spirit of innovation within the pharmaceutical industry. His extensive work and patents illustrate his commitment to developing new processes that advance healthcare solutions, ensuring a lasting impact on both science and society.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…